Cover Image

B-cell maturation antigen-specific chimeric antigen receptor T cells for multiple myeloma: clinical experience and future perspectives

Despite major advances in the treatment of multiple myeloma (MM), it remains a largely incurable disease with long-term control often dependent on continuous therapy. More effective, better tolerated treatments are therefore required to achieve durable remissions and to improve the quality of life o...

Full description

Saved in:
Bibliographic Details
Main Authors: Sellner, Leopold (Author) , Fan, Fuli (Author) , Giesen, Nicola (Author) , Schubert, Maria-Luisa (Author) , Goldschmidt, Hartmut (Author) , Müller-Tidow, Carsten (Author) , Dreger, Peter (Author) , Raab, Marc-Steffen (Author) , Schmitt, Michael (Author)
Format: Article (Journal)
Language:English
Published: 2020
In: International journal of cancer
Year: 2020, Volume: 147, Issue: 8, Pages: 2029-2041
ISSN:1097-0215
DOI:10.1002/ijc.33002
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/ijc.33002
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/10.1002/ijc.33002
Get full text
Author Notes:Leopold Sellner, Fuli Fan, Nicola Giesen, Maria-Luisa Schubert, Hartmut Goldschmidt, Carsten Müller-Tidow, Peter Dreger, Marc S. Raab, Michael Schmitt
Description
Summary:Despite major advances in the treatment of multiple myeloma (MM), it remains a largely incurable disease with long-term control often dependent on continuous therapy. More effective, better tolerated treatments are therefore required to achieve durable remissions and to improve the quality of life of MM patients.
Item Description:First published: 09 April 2020
Gesehen am 05.01.2022
Physical Description:Online Resource
ISSN:1097-0215
DOI:10.1002/ijc.33002

Similar Items